Moderate to Severe Rheumatoid Arthritis

Immunology·MeSH: Arthritis, Rheumatoid

Prevalence

800.0 / 100K

Incidence

41.0 / 100K/yr

6 drugs in development·4 companies·1 clinical trial

Drug Pipeline by Phase

Compare drugs

indocin vs INDOCIN (suppositories and oral suspension)indocin vs INDOCIN Suppositoriesindocin vs indomethacin

Frequently asked questions

How many drugs are in development for Moderate to Severe Rheumatoid Arthritis?

BioSniper tracks 6 drugs in development for Moderate to Severe Rheumatoid Arthritis across 4 companies.

How many clinical trials target Moderate to Severe Rheumatoid Arthritis?

There are 1 clinical trial targeting Moderate to Severe Rheumatoid Arthritis tracked by BioSniper.

What is the prevalence of Moderate to Severe Rheumatoid Arthritis?

The estimated prevalence of Moderate to Severe Rheumatoid Arthritis is approximately 800.0 per 100,000 population.

Deep-dive into Moderate to Severe Rheumatoid Arthritis

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Moderate to Severe Rheumatoid Arthritis — Drugs in Development & Clinical Trials | BioSniper